Homocysteine and peripheral arterial disease: systematic review and meta-analysis.

[1]  N. Mayo,et al.  Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[2]  N. Powe,et al.  Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients. , 2007, Advances in chronic kidney disease.

[3]  Xiping Xu,et al.  Efficacy of folic acid supplementation in stroke prevention: a meta-analysis , 2007, The Lancet.

[4]  K. Bailey,et al.  Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations. , 2007, Mayo Clinic proceedings.

[5]  L. M. Srivastava,et al.  Prevalence of Hyperhomocysteinemia in Vascular Disease: Comparative Study of Thrombotic Venous Disease Vis-è-Vis Occlusive Arterial Disease , 2007, Vascular.

[6]  K. Reynolds,et al.  Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. , 2006, JAMA.

[7]  E. Minar,et al.  No effect of homocysteine‐lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease , 2006, European journal of clinical investigation.

[8]  J. Carrero,et al.  Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. , 2005, The Journal of nutrition.

[9]  M. Wolzt,et al.  Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease. , 2005, The Journal of clinical endocrinology and metabolism.

[10]  F. Sofi,et al.  Thrombophilic risk factors for symptomatic peripheral arterial disease. , 2005, Journal of vascular surgery.

[11]  T. Mueller,et al.  Hyperhomocysteinemia and severity of peripheral vascular disease: a rebuttal , 2004, Journal of thrombosis and haemostasis : JTH.

[12]  N. Day,et al.  Dietary folate and vitamin B6 are independent predictors of peripheral arterial occlusive disease. , 2004, Journal of vascular surgery.

[13]  A. Castelnuovo,et al.  Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients , 2003, Journal of thrombosis and haemostasis : JTH.

[14]  P. Laws,et al.  The incidence of hyperhomocysteinaemia in vascular patients. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[15]  A. Algra,et al.  Hyperhomocysteinemia and risk for peripheral arterial occlusive disease in young women. , 2003, Journal of vascular surgery.

[16]  J. Allenberg,et al.  Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross‐sectional study of 6880 primary care patients , 2003, European journal of clinical investigation.

[17]  Eric J Topol,et al.  Critical issues in peripheral arterial disease detection and management: a call to action. , 2003, Archives of internal medicine.

[18]  A. Algra,et al.  Novel risk factors for peripheral arterial disease in young women. , 2002, The American journal of medicine.

[19]  J. Filipovský,et al.  Treatment of Hyperhomocysteinemia with Folic Acid: Effects on Homocysteine Levels, Coagulation Status, and Oxidative Stress Markers , 2002, Journal of Cardiovascular Pharmacology.

[20]  H. Stricker,et al.  Homocysteine, vitamins and gene mutations in peripheral arterial disease , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[21]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[22]  A. Deussen,et al.  Screening of plasma homocysteine in peripheral arterial disease , 2001, Annals of medicine.

[23]  D. Bunout,et al.  Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls. , 2000, Nutrition.

[24]  G. Lowe,et al.  Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. , 2000, Atherosclerosis.

[25]  W. Herrmann,et al.  Plasma Homocysteine and Lipoprotein Profile in Patients with Peripheral Arterial Occlusive Disease , 2000, Angiology.

[26]  K. Woo,et al.  Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. , 1999, Journal of the American College of Cardiology.

[27]  G. Breithardt,et al.  Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[28]  P. Reitsma,et al.  The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. , 1998, Atherosclerosis.

[29]  D. Hogan,et al.  Folate status, vascular disease and cognition in elderly Canadians. , 1998, Age and ageing.

[30]  J. Witteman,et al.  Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. , 1998, Circulation.

[31]  Stephen W. K. Cheng,et al.  Fasting Total Plasma Homocysteine and Atherosclerotic Peripheral Vascular Disease , 1997, Annals of vascular surgery.

[32]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[33]  P. Lønning,et al.  Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[34]  P. Lundberg,et al.  Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[35]  G. Rodgers,et al.  Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  U. de Faire,et al.  Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease. , 1993, European journal of vascular surgery.

[37]  A. Olsson,et al.  Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication , 1992, Journal of internal medicine.

[38]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[39]  B. Norrving,et al.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. , 1990, Atherosclerosis.

[40]  L. Taylor,et al.  Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.

[41]  K. Mccully.  Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. , 1969, The American journal of pathology.

[42]  Y. van der Graaf,et al.  The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease. , 2007, Journal of vascular surgery.

[43]  D. Tsikas,et al.  ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. , 2003, Cardiovascular research.

[44]  G. Moneta,et al.  Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. , 1999, Journal of vascular surgery.

[45]  R. J. Valentine,et al.  Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. , 1996, Journal of vascular surgery.

[46]  C. Stehouwer,et al.  Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[47]  L. Taylor,et al.  The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. , 1991, Journal of vascular surgery.